Rebuked by the FDA for quality control issues, Redmond’s Physio-Control has been limited for almost a year to selling its LIFEPAK defibrillators in the United States to emergency service providers, such as paramedics and emergency medical technicians.
Now, Chelmsford, Mass.-based Zoll Medical, a major competitor, is aggressively going after that market, questioning why emergency service providers are continuing to buy Physio-Control’s products when the FDA has banned them from being sold to other customers.
In a survey of paramedics and emergency medical technicians, conducted by an independent firm but paid for by Zoll, most respondents said they had not heard of Physio-Control’s travails. But half of the respondents who said they planned to buy Physio-Control’s products said they knew about the company’s troubles with the FDA.
Click here to read more.